🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kuangli Bio-Tech Holdings Co., Ltd. (TPE:6431)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.25
-1.05 (-6.86%)
Nov 20, 2026, 1:30 PM CST

Kuangli Bio-Tech Holdings Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
90.86208.9341.5963.22141.89162.17
Short-Term Investments
---9.19--
Cash & Short-Term Investments
90.86208.9341.5972.41141.89162.17
Cash Growth
-51.50%402.40%-42.57%-48.97%-12.51%41.71%
Accounts Receivable
96.185.26101.8273.0196.86135.93
Other Receivables
8.70.412.010.281.8485.76
Receivables
104.885.66118.53135.86163.32231.68
Inventory
105.1953.3664.2452.1363.6598.87
Prepaid Expenses
--2.692.799.789.55
Other Current Assets
30.95115.8922.1642.5221.1620.85
Total Current Assets
331.79463.84249.2305.7399.79523.13
Property, Plant & Equipment
433.82418.88319.86380.64361.44368.49
Long-Term Investments
1.773----
Goodwill
-98.89107.17128.81140.42138.38
Other Intangible Assets
241.87146.11166169.43189.61203.62
Long-Term Accounts Receivable
-4.527.8211.07--
Long-Term Deferred Tax Assets
48.245.845.6234.6915.781.59
Other Long-Term Assets
64.756.314.5412.938.5213.9
Total Assets
1,1221,187910.21,0431,1161,249

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
49.4249.1756.5322.3529.6695.15
Accrued Expenses
----16.8716.33
Short-Term Debt
107.46176.11134.34147.37148.42147.7
Current Portion of Long-Term Debt
-8.2530.0342.089.92-
Current Portion of Leases
42.9640.3832.7332.3221.2724.37
Current Income Taxes Payable
0.44---2.824.69
Current Unearned Revenue
45.429.9916.6910.812.712.83
Other Current Liabilities
73.6638.437.6328.1831.0127.13
Total Current Liabilities
319.34342.29307.95283.11272.66328.19
Long-Term Debt
23.346.176.2521.3812.18-
Long-Term Leases
289.11256.43133.47178.37157.97176.27
Other Long-Term Liabilities
2.932.122.562.49-2.18
Total Liabilities
634.72607.01450.24485.34442.81506.63

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
973.99973.99723.99572.39572.39511.71
Additional Paid-In Capital
274.93274.93204.33187.28187.28251.72
Retained Earnings
-751.09-637.91-444.93-272.14-167.98-243.23
Comprehensive Income & Other
-10.35-33.62-23.41-42.91-32.26-37.92
Total Common Equity
487.48577.39459.97444.62559.44482.27
Minority Interest
-2.94---260.2
Shareholders' Equity
487.48580.32459.97557.92672.74742.47
Total Liabilities & Equity
1,1221,187910.21,0431,1161,249

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
462.88487.33336.82421.52349.75348.33
Net Cash (Debt)
-372.02-278.4-295.24-349.11-207.86-186.15
Net Cash Growth
------
Net Cash Per Share
-3.82-2.99-4.30-6.10-3.69-3.67
Filing Date Shares Outstanding
97.497.472.457.2457.2451.17
Total Common Shares Outstanding
97.497.472.457.2457.2451.17
Working Capital
12.45121.55-58.7522.59127.13194.94
Book Value Per Share
5.005.936.357.779.779.42
Tangible Book Value
245.61332.38186.8146.38229.41140.28
Tangible Book Value Per Share
2.523.412.582.564.012.74
Machinery
-122.35119.75116.2175.91127.91
Construction In Progress
----129.2642.28
Leasehold Improvements
-145.37138.89135.0124.9154.63